Abstract:The lifestyle of modern society has changed significantly with the emergence of artificial intelligence (AI), machine learning (ML), and deep learning (DL) technologies in recent years. Artificial intelligence is a multidimensional technology with various components such as advanced algorithms, ML and DL. Together, AI, ML, and DL are expected to provide automated devices to ophthalmologists for early diagnosis and timely treatment of ocular disorders in the near future. In fact, AI, ML, and DL have been used in ophthalmic setting to validate the diagnosis of diseases, read images, perform corneal topographic mapping and intraocular lens calculations. Diabetic retinopathy (DR), age-related macular degeneration (AMD), and glaucoma are the 3 most common causes of irreversible blindness on a global scale. Ophthalmic imaging provides a way to diagnose and objectively detect the progression of a number of pathologies including DR, AMD, glaucoma, and other ophthalmic disorders. There are 2 methods of imaging used as diagnostic methods in ophthalmic practice: fundus digital photography and optical coherence tomography (OCT). Of note, OCT has become the most widely used imaging modality in ophthalmology settings in the developed world. Changes in population demographics and lifestyle, extension of average lifespan, and the changing pattern of chronic diseases such as obesity, diabetes, DR, AMD, and glaucoma create a rising demand for such images. Furthermore, the limitation of availability of retina specialists and trained human graders is a major problem in many countries. Consequently, given the current population growth trends, it is inevitable that analyzing such images is time-consuming, costly, and prone to human error. Therefore, the detection and treatment of DR, AMD, glaucoma, and other ophthalmic disorders through unmanned automated applications system in the near future will be inevitable. We provide an overview of the potential impact of the current AI, ML, and DL methods and their applications on the early detection and treatment of DR, AMD, glaucoma, and other ophthalmic diseases.

Artificial Intelligence (AI) enable advanced and accurate diagnostics eye health station for critical eye conditions

Application of Artificial Intelligence in Ophthalmology: An Updated Comprehensive Review

Artificial Intelligence (AI) for Early Diagnosis of Retinal Diseases

Promising Artificial Intelligence-Machine Learning-Deep Learning Algorithms in Ophthalmology

Artificial Intelligence in Ophthalmic Surgery: Current Applications and Expectations

Artificial intelligence for retinal diseases

Artificial intelligence in retinal disease: clinical application, challenges, and future directions

Novel Approaches for Early Detection of Retinal Diseases Using Artificial Intelligence

Artificial intelligence in the anterior segment of eye diseases

Novel artificial intelligence algorithms for diabetic retinopathy and diabetic macular edema

Future of artificial intelligence for the diagnosis and treatment of retinal diseases

Eyes: The Gateway to Brain Health—Advancing Disease Detection and Patient Accessibility

Artificial intelligence for home monitoring devices

Artificial intelligence in individualized retinal disease management

Artificial intelligence in ophthalmology: the present and the future

Artificial Intelligence in Ophthalmology – Status Quo and Future Perspectives

An overview of artificial intelligence in diabetic retinopathy and other ocular diseases

Artificial Intelligence Screening for Diabetic Retinopathy: the Real-World Emerging Application

Planning an artificial intelligence diabetic retinopathy screening program: a human-centered design approach

Application of artificial intelligence in cataract management: current and future directions

Integrated Diagnosis, Treatment and Prognosis in Healthcare using Artificial Intelligence